There is much interest in the role of probiotics in the human-bacterial interaction, inter-bacterial interaction and how these effects could be utilised for disease management and prevention.

This is understandable as the adverse impacts of widespread antibiotic use become evident.

In addition, we are learning that a rich and diverse microbiome is likely to play an important role in developing a sound immune system and modulating the risk of developing inflammatory conditions later in life.

In this context, the potential role of probiotics as an alternative treatment option to antibiotics for infection prevention and in modifying inflammatory diseases has come into focus.